Product Code: GVR-4-68040-310-0
Phosphoramidite Market Growth & Trends:
The global phosphoramidite market size is expected to reach USD 1.76 billion by 2030, growing at a CAGR of 7.37% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for phosphoramidite in pharmaceuticals and advancements in biotechnology and life sciences are the factors anticipated to drive the market growth. The growing demand for customized DNA and RNA synthesis is also expected to boost the growth.Moreover, the rising investments in healthcare and life sciences research are projected to propel the growth.
Governments, academic institutions, and private organizations are investing significantly in healthcare and life sciences research. This investment fosters innovation and drives the development of new applications for phosphoramidites, fueling market growth. For instance, in January 2024, The Development Bank of Japan (DBJ) is providing financial support to a life science investment firm, 4BIO Partners LLP, in the UK. This investment is expected to be between USD 200 million and USD 300 million in size. 4BIO Partners LLP is focusing on private companies involved in the development of advanced cell and gene therapy, RNA-based therapy, microbiome support, and other emerging technologies within the health tech sector.
The COVID-19 pandemic has had a significant impact on the industry. The pandemic has boosted research efforts across the globe, particularly in virology, immunology, and molecular biology, leading to a surge in demand for oligonucleotides synthesized using phosphoramidites. This increased demand for research purposes has positively impacted on the market. The urgency to develop treatments and vaccines for COVID-19 has accelerated drug development processes.
Phosphoramidites are crucial in the synthesis of nucleic acid-based therapeutics, including mRNA vaccines and antisense oligonucleotide drugs, driving the demand for phosphoramidites. While COVID-19 research has increased demand for certain applications, research in other areas has been deprioritized or postponed during the pandemic. This shift in research priorities has implications for the demand for phosphoramidites in specific applications, affecting market dynamics.
The manufacture and use of phosphoramidites are subject to regulatory oversight regarding safety, environmental impact, and intellectual property rights. Compliance with evolving regulations and obtaining necessary approvals can take time and effort, posing challenges for market players. Phosphoramidite synthesis and oligonucleotide production require specialized equipment, expertise, and stringent quality control measures. Developing and maintaining the infrastructure and technical capabilities necessary for phosphoramidite manufacturing can be challenging for smaller companies and new entrants.
Phosphoramidite Market Report Highlights:
- DNA phosphoramidites dominated the type segment with a revenue share of 36.57% in 2023
- The RNA phosphoramidites type segment is expected to register the fastest CAGR over the forecast period
- Drug discovery & development dominated the application segment in 2023 and is expected to grow at the fastest CAGR during the forecast period
- Based on end-use, the pharmaceutical & biotechnology companies segment dominated the market in 2023 and is expected to grow at the fastest CAGR during the forecast period
- North America dominated the market with a revenue share of 39.71% in 2023, owing to the factors such as the high purchasing power parity, government support for quality healthcare, and availability of reimbursement
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.2.1. Type
- 1.2.2. Application
- 1.2.3. End-use
- 1.3. Information analysis
- 1.4. Market formulation & data visualization
- 1.5. Data validation & publishing
- 1.6. Information Procurement
- 1.7. Information or Data Analysis
- 1.8. Market Formulation & Validation
- 1.9. Market Model
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Growth of oligonucleotide therapies
- 3.2.1.2. Advancements in genomics and personalized medicine
- 3.2.1.3. Growth in synthetic biology research
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Stringent regulations for oligonucleotide therapies
- 3.2.2.2. Difficulties in long chain synthesis
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
Chapter 4. Phosphoramidite Market: Type Business Analysis
- 4.1. Type Segment Dashboard
- 4.2. Global Phosphoramidite Market Type Movement Analysis
- 4.3. Global Phosphoramidite Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
- 4.4. DNA Phosphoramidites
- 4.4.1. Global DNA Phosphoramidites Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. RNA Phosphoramidites
- 4.5.1. Global RNA Phosphoramidites Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Labeled Phosphoramidites
- 4.6.1. Global Labeled Phosphoramidites Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7. Modifier Phosphoramidites
- 4.7.1. Global Modifier Phosphoramidites Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.8. Others
- 4.8.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Phosphoramidite Market: Application Business Analysis
- 5.1. Application Segment Dashboard
- 5.2. Global Phosphoramidite Market Application, Movement Analysis
- 5.3. Global Phosphoramidite Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 5.4. Drug Discovery & Development
- 5.4.1. Global Drug Discovery & DevelopmentMarket Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5. Diagnostics Development
- 5.5.1. Global Diagnostics Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Others
- 5.6.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Phosphoramidite Market: End-use Business Analysis
- 6.1. End-use Segment Dashboard
- 6.2. Global Phosphoramidite Market End-use Movement Analysis
- 6.3. Global Phosphoramidite Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
- 6.4. Pharmaceutical & Biotechnology Companies
- 6.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5. Academic & Research Institutes
- 6.5.1. Global Academic & Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Others
- 6.6.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Phosphoramidite Market: Regional Estimates & Trend Analysis
- 7.1. Regional Dashboard
- 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
- 7.3. North America
- 7.3.1. North America Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. Competitive Scenario
- 7.3.2.3. Regulatory Framework
- 7.3.2.4. U.S. Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Canada
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Competitive Scenario
- 7.3.3.3. Regulatory Framework
- 7.3.3.4. Canada Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Competitive Scenario
- 7.3.4.3. Regulatory Framework
- 7.3.4.4. Mexico Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4. Europe
- 7.4.1. Europe Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. UK
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Competitive Scenario
- 7.4.2.3. Regulatory Framework
- 7.4.2.4. UK Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Germany
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Competitive Scenario
- 7.4.3.3. Regulatory Framework
- 7.4.3.4. Germany Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Competitive Scenario
- 7.4.4.3. Regulatory Framework
- 7.4.4.4. France Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Competitive Scenario
- 7.4.5.3. Regulatory Framework
- 7.4.5.4. Italy Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Competitive Scenario
- 7.4.6.3. Regulatory Framework
- 7.4.6.4. Spain Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.7. Denmark
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Competitive Scenario
- 7.4.7.3. Regulatory Framework
- 7.4.7.4. Denmark Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.8. Sweden
- 7.4.8.1. Key Country Dynamics
- 7.4.8.2. Competitive Scenario
- 7.4.8.3. Regulatory Framework
- 7.4.8.4. Sweden Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.9. Norway
- 7.4.9.1. Key Country Dynamics
- 7.4.9.2. Competitive Scenario
- 7.4.9.3. Regulatory Framework
- 7.4.9.4. Norway Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Asia Pacific Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. Japan
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Japan Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. China
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. China Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. India
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Competitive Scenario
- 7.5.4.3. Regulatory Framework
- 7.5.4.4. India Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.5. Australia
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. Competitive Scenario
- 7.5.5.3. Regulatory Framework
- 7.5.5.4. Australia Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.6. Thailand
- 7.5.6.1. Key Country Dynamics
- 7.5.6.2. Competitive Scenario
- 7.5.6.3. Regulatory Framework
- 7.5.6.4. Thailand Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.7. South Korea
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Competitive Scenario
- 7.5.7.3. Regulatory Framework
- 7.5.7.4. South Korea Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6. Latin America
- 7.6.1. Latin America Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Brazil Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Argentina Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7. MEA
- 7.7.1. MEA Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.2. South Africa
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. South Africa Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.3. Saudi Arabia
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. Saudi Arabia Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.4. UAE
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. Regulatory Framework
- 7.7.4.4. UAE Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.5. Kuwait
- 7.7.5.1. Key Country Dynamics
- 7.7.5.2. Competitive Scenario
- 7.7.5.3. Regulatory Framework
- 7.7.5.4. Kuwait Phosphoramidite Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Participant Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Position Analysis, 2023
- 8.4. Participant's Overview
- 8.4.1. BOC Sciences
- 8.4.1.1. Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Product Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. Thermo Fisher Scientific Inc.
- 8.4.2.1. Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Product Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. Merck KGaA
- 8.4.3.1. Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Product Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. Glen Research
- 8.4.4.1. Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Product Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. LGC Biosearch Technologies
- 8.4.5.1. Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Product Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. Biosynth
- 8.4.6.1. Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Product Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. BIONEER CORPORATION
- 8.4.7.1. Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Product Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. QIAGEN
- 8.4.8.1. Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Product Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. PolyOrg, Inc
- 8.4.9.1. Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Product Benchmarking
- 8.4.9.4. Strategic Initiatives
- 8.4.10. Lumiprobe Corporation
- 8.4.10.1. Overview
- 8.4.10.2. Financial Performance
- 8.4.10.3. Product Benchmarking
- 8.4.10.4. Strategic Initiatives